drugset / Trial / NCT04167943

Conservative Pulp Therapy of Primary Molars Using TheraCAL

NCT04167943

Phase 3 Completed 216 enrolled Ain Shams University
Non-randomizedParallel-groupDouble-blindTreatment

Summary

The study is a clinical trial that assesses the clinical and radiographic success rates of 3 conservative pulp therapy treatments in primary molars compared to conventional pulpotomy using a bioactive dual cured calcium silicate cement (TheraCAL PT).

Timeline

Start
2019-11-25
Primary completion
2021-08-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject TheraCal PT Other / unclassified

Indications